SCHEMBL18068191

SCHEMBL18068191

O=C1c2ccccc2C(=O)N1Cc1cc(Cl)nc(C2CC2)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.46
▸ RECQL P46063 2/20 0.46
▸ ALDH1A1 P00352 4/20 0.44
▸ KMT2A Q03164 3/20 0.44
▸ PKM P14618 2/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ TYR P14679 3/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ ACHE P22303 1/20 0.40
▸ HTT P42858 3/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ TSHR P16473 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ CASP3 P42574 1/20 0.39
▸ GAA P10253 1/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29411219 0.80 ALDH1A1 (0.51) MAPTRECQLALDH1A1KMT2APKM
SCHEMBL3720990 0.80 ALDH1A1 (0.51) MAPTRECQLALDH1A1KMT2APKM
SCHEMBL17979197 0.79 MAPT (0.46) MAPTRECQLALDH1A1KMT2APKM
SCHEMBL29411267 0.79 MAPT (0.46) MAPTRECQLALDH1A1KMT2APKM
SCHEMBL18489369 0.78 MAPT (0.54) MAPTRECQLALDH1A1KMT2APKM
SCHEMBL17979249 0.77 ALDH1A1 (0.51) MAPTRECQLALDH1A1KMT2APKM
SCHEMBL29411247 0.77 ALDH1A1 (0.51) MAPTRECQLALDH1A1KMT2APKM
SCHEMBL19795357 0.76 MAPT (0.52) MAPTRECQLALDH1A1KMT2APKM
SCHEMBL18069125 0.75 ALDH1A1 (0.39) MAPTRECQLALDH1A1KMT2APKM
SCHEMBL10844171 0.75 RECQL (0.47) MAPTRECQLALDH1A1KMT2APKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10179782-B2 Substituted sulfonamide compounds GENENTECH, INC. (US) 2019-01-15 — — US disclosed
US-20160264567-A1 SUBSTITUTED SULFONAMIDE COMPOUNDS GENENTECH, INC. (US) 2016-09-15 — — US disclosed
US-20160264567-A1 SUBSTITUTED SULFONAMIDE COMPOUNDS GENENTECH, INC. (US) 2016-09-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10179782-B2 Substituted sulfonamide compounds TRPA1, TRPV1, TRPV5 MAPT 4093/4885RECQL 2373/4885ALDH1A1 461/4885
US-20160264567-A1 SUBSTITUTED SULFONAMIDE COMPOUNDS TRPA1, TRPV1, TRPV5 MAPT 4093/4885RECQL 2373/4885ALDH1A1 461/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback